首页 > 最新文献

Therapia Hungarica (English edition)最新文献

英文 中文
Relationship between the immune system and the diseases of the central nervous system. 免疫系统与中枢神经系统疾病的关系。
Pub Date : 1992-01-01
M Bokor, A Faragó, R Schnabel, T Garam

Considering the eventual role of non-specific cell-mediated immune reactions in the pathogenesis of Parkinson's syndrome based on the destruction of dopaminergic cells of the substantia nigra the killer cell activity of patients suffering from this disease has been examined. According to the results the killer cell activity of Parkinson patients is significantly lower in the age group below 60 years as compared to the higher age groups. When comparing the age groups below 60 years, significantly lower activity was measured in the patients than in the controls. Killer cell activity is significantly higher in patients suffering from more severe conditions (Hoehn-Yahr's stage IV-V) when compared to the milder cases. These results suggest the possibility that killer cell-mediated ADCC reaction may play a role in the pathogenesis of the disease. The results of these examinations open new therapeutic perspectives. It may be hoped that, as a result of our increasing knowledge and technical progress in immunology, the damaged immune system could be selectively influenced and target specific immune therapy could be used in the near future by means of for instance inactivations of cytotoxic cells, elimination of antibodies or other immunological methods.

考虑到非特异性细胞介导的免疫反应在帕金森综合征发病机制中的最终作用,基于黑质多巴胺能细胞的破坏,已经检查了患有这种疾病的患者的杀伤细胞活性。研究结果显示,60岁以下帕金森患者的杀伤细胞活性明显低于年龄较大的帕金森患者。当比较60岁以下年龄组时,患者的活动量明显低于对照组。与病情较轻的患者相比,病情较严重的患者(Hoehn-Yahr's IV-V期)的杀伤细胞活性明显较高。这些结果提示,杀伤细胞介导的ADCC反应可能在该疾病的发病机制中发挥作用。这些检查的结果开辟了新的治疗前景。我们希望,随着我们在免疫学方面知识的增长和技术的进步,受损的免疫系统可以被选择性地影响,在不久的将来,通过细胞毒性细胞的失活、抗体的消除或其他免疫学方法,靶向特异性免疫治疗可以被使用。
{"title":"Relationship between the immune system and the diseases of the central nervous system.","authors":"M Bokor,&nbsp;A Faragó,&nbsp;R Schnabel,&nbsp;T Garam","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Considering the eventual role of non-specific cell-mediated immune reactions in the pathogenesis of Parkinson's syndrome based on the destruction of dopaminergic cells of the substantia nigra the killer cell activity of patients suffering from this disease has been examined. According to the results the killer cell activity of Parkinson patients is significantly lower in the age group below 60 years as compared to the higher age groups. When comparing the age groups below 60 years, significantly lower activity was measured in the patients than in the controls. Killer cell activity is significantly higher in patients suffering from more severe conditions (Hoehn-Yahr's stage IV-V) when compared to the milder cases. These results suggest the possibility that killer cell-mediated ADCC reaction may play a role in the pathogenesis of the disease. The results of these examinations open new therapeutic perspectives. It may be hoped that, as a result of our increasing knowledge and technical progress in immunology, the damaged immune system could be selectively influenced and target specific immune therapy could be used in the near future by means of for instance inactivations of cytotoxic cells, elimination of antibodies or other immunological methods.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 2","pages":"51-7"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12631557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical observations with Paxirasol nasal spray. 帕西拉索尔鼻喷雾剂的临床观察。
Pub Date : 1992-01-01
H Szabadka

The effect of Paxirasol nasal spray has been examined in 25 patients by the open method. The goal of the study was to assess and evaluate the clinical effectivity of the product and to observe the eventual side-effects. Among the examined patients 14 were acute and 11 chronic disease cases. In 20 of the 25 patients treated with Paxirasol nasal spray the pathological alteration of the nasal mucosa was controlled, mild alteration persisted in 4 patients, and moderately severe condition in 1 patient. The product significantly improved the viscosity of nasal discharge in all of them. The cessation or moderation of difficult nose blowing improved the general condition of the patients and accelerated recovery. Occasionally manifesting olfactory disorders ceased as well. The treatment needed not be discontinued because of the development of side-effects. Considering the healing tendency difference could be observed between the acute and chronic cases, especially in rhinitis sicca patients who were treated with Paxirasol nasal spray. In 23 of the 25 patients notable improvement of both the subjective and objective symptoms was observed. Paxirasol nasal spray is of value in very frequently occurring diseases of the nasal mucosa accompanied by dehydration. In the majority of acute disease patients the use of the product as monotherapy may result in complete cessation of symptoms.

采用开放式方法对25例帕西拉索鼻喷雾剂的疗效进行了观察。该研究的目的是评估和评价该产品的临床有效性,并观察最终的副作用。其中急性病14例,慢性病11例。25例患者中,20例鼻黏膜病理改变得到控制,4例轻度改变持续,1例中重度改变。该产品显著改善了所有患者的鼻分泌物粘度。困难擤鼻涕的停止或适度改善了患者的一般情况,加速了康复。偶尔表现出的嗅觉障碍也停止了。治疗不需要因为出现副作用而中断。考虑到急性和慢性鼻炎患者的愈合趋势存在差异,特别是在使用帕西拉索尔鼻喷雾剂治疗的鼻炎患者中。25例患者中有23例主客观症状均有显著改善。帕西拉索鼻喷雾剂对经常发生的伴有脱水的鼻黏膜疾病很有价值。在大多数急性疾病患者中,使用本品作为单一疗法可导致症状完全停止。
{"title":"Clinical observations with Paxirasol nasal spray.","authors":"H Szabadka","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effect of Paxirasol nasal spray has been examined in 25 patients by the open method. The goal of the study was to assess and evaluate the clinical effectivity of the product and to observe the eventual side-effects. Among the examined patients 14 were acute and 11 chronic disease cases. In 20 of the 25 patients treated with Paxirasol nasal spray the pathological alteration of the nasal mucosa was controlled, mild alteration persisted in 4 patients, and moderately severe condition in 1 patient. The product significantly improved the viscosity of nasal discharge in all of them. The cessation or moderation of difficult nose blowing improved the general condition of the patients and accelerated recovery. Occasionally manifesting olfactory disorders ceased as well. The treatment needed not be discontinued because of the development of side-effects. Considering the healing tendency difference could be observed between the acute and chronic cases, especially in rhinitis sicca patients who were treated with Paxirasol nasal spray. In 23 of the 25 patients notable improvement of both the subjective and objective symptoms was observed. Paxirasol nasal spray is of value in very frequently occurring diseases of the nasal mucosa accompanied by dehydration. In the majority of acute disease patients the use of the product as monotherapy may result in complete cessation of symptoms.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 1","pages":"31-6"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12753301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Klion suspension in paediatry and gynaecology. Klion悬浮液在儿科和妇科的应用。
Pub Date : 1992-01-01
G Takács

Klion suspension was given to 42 girl and woman patients suffering from vaginal trichomoniasis. Negativity for Trichomonas was recorded in 73.8% of the cases in response to the first 10-day cure, and in 90.5% of the patients following repeated cures. The therapy had no notable side-effects. The liquid form of the medicine proved to be advantageous especially in the treatment of young girls but the possibility to take the drug diluted in soft drinks also facilitated the treatment of the partner.

42名患有阴道滴虫病的女孩和妇女服用了Klion悬浮液。在第一个10天治愈的病例中,滴虫阴性率为73.8%,在重复治疗后,滴虫阴性率为90.5%。这种疗法没有明显的副作用。药物的液体形式被证明是有利的,特别是在治疗年轻女孩,但服用稀释在软饮料中的药物的可能性也促进了对伴侣的治疗。
{"title":"Use of Klion suspension in paediatry and gynaecology.","authors":"G Takács","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Klion suspension was given to 42 girl and woman patients suffering from vaginal trichomoniasis. Negativity for Trichomonas was recorded in 73.8% of the cases in response to the first 10-day cure, and in 90.5% of the patients following repeated cures. The therapy had no notable side-effects. The liquid form of the medicine proved to be advantageous especially in the treatment of young girls but the possibility to take the drug diluted in soft drinks also facilitated the treatment of the partner.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 4","pages":"189-91"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12517330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examinations of the relative fluidity in cerebrovascular disease patients. 脑血管病患者的相对流动性检查。
Pub Date : 1992-01-01
A Szobor, M Klein

Parallel with the increasing incidence of cerebrovascular diseases, and the limitations of possible surgical methods, the importance of drug therapy has significantly increased. Due to our knowledge of haemorheology the effectiveness of therapies may be measured by means of useful circulatory markers. In course of our research activities of one and a half decades the changes in blood viscosity were measured during vinpocetine therapy, and were compared to the changes of haematocrit and mean corpuscular volume (MCV) values. The effect of vinpocetine and secale alkaloids or vinpocetine and pentoxifylline were compared by sequential analysis in other cases. The results of these examinations proved that vinpocetine is effective in both short and long-term therapy.

随着脑血管疾病发病率的增加,以及可能的手术方法的局限性,药物治疗的重要性显著增加。由于我们对血液流变学的了解,治疗的有效性可以通过有用的循环标志物来衡量。在十五年的研究过程中,我们测量了长春西汀治疗期间血液粘度的变化,并将其与红细胞压积和平均红细胞体积(MCV)值的变化进行了比较。其余病例采用序列分析比较长春西汀与鳞片生物碱或长春西汀与己酮茶碱的疗效。这些检查结果证明长春西汀在短期和长期治疗中都有效。
{"title":"Examinations of the relative fluidity in cerebrovascular disease patients.","authors":"A Szobor,&nbsp;M Klein","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Parallel with the increasing incidence of cerebrovascular diseases, and the limitations of possible surgical methods, the importance of drug therapy has significantly increased. Due to our knowledge of haemorheology the effectiveness of therapies may be measured by means of useful circulatory markers. In course of our research activities of one and a half decades the changes in blood viscosity were measured during vinpocetine therapy, and were compared to the changes of haematocrit and mean corpuscular volume (MCV) values. The effect of vinpocetine and secale alkaloids or vinpocetine and pentoxifylline were compared by sequential analysis in other cases. The results of these examinations proved that vinpocetine is effective in both short and long-term therapy.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 1","pages":"8-11"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12752482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Tensiomin in hypertensive patients with impaired renal function. 张力蛋白在高血压肾功能受损患者中的应用。
Pub Date : 1992-01-01
J Makó, M Potyondi

Tensiomin treatment was applied in 20 hypertensive patients with impaired renal function but not requiring dialysis therapy and in 18 patients undergoing regular dialysis. In patients still not requiring dialysis the slowing down of the progression of renal failure, in the dialysed patients insufficient earlier therapy were the indications of Tensiomin treatment. Tensiomin was found to be an effective hypotensive drug in both groups, the majority of the side-effects were mild and of temporary character. The progression of renal failure was slower in the non-dialysed patients compared to the control group but the differences were statistically insignificant.

对20例肾功能受损但不需要透析治疗的高血压患者和18例常规透析患者进行了张力蛋白治疗。在仍不需要透析的患者中,肾功能衰竭进展的减缓,在透析患者早期治疗不足是Tensiomin治疗的适应症。两组均发现张力蛋白是有效的降压药物,副作用多为轻微和暂时性的。与对照组相比,非透析组患者肾功能衰竭的进展较慢,但差异无统计学意义。
{"title":"Use of Tensiomin in hypertensive patients with impaired renal function.","authors":"J Makó,&nbsp;M Potyondi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Tensiomin treatment was applied in 20 hypertensive patients with impaired renal function but not requiring dialysis therapy and in 18 patients undergoing regular dialysis. In patients still not requiring dialysis the slowing down of the progression of renal failure, in the dialysed patients insufficient earlier therapy were the indications of Tensiomin treatment. Tensiomin was found to be an effective hypotensive drug in both groups, the majority of the side-effects were mild and of temporary character. The progression of renal failure was slower in the non-dialysed patients compared to the control group but the differences were statistically insignificant.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 1","pages":"20-4"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12753297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paul Zoll and the discovery of pacemaker. 保罗·佐尔和心脏起搏器的发现。
Pub Date : 1992-01-01
P Braun
{"title":"Paul Zoll and the discovery of pacemaker.","authors":"P Braun","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 1","pages":"44-6"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12752481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How rapid is the return of fertility after the use of Tri-Regol oral contraceptive? 使用Tri-Regol口服避孕药后恢复生育能力的速度有多快?
Pub Date : 1992-01-01
J Adám

The study deals with the return of fertility following the discontinuance of the use of different oral contraceptives. On the basis of the evaluation of data of 222 cases the following were concluded: after the discontinuance of the use of oral contraceptives for a shorter-longer period delay may be observed in the return of fertility. This was not longer that 7 months in the evaluated cases. Compared to monophasic tablets, following the use of multiphasic tablets (Anteovin, Tri-Regol) regeneration, that is first ovulation and the following pregnancy, occur within a shorter period. The role of the duration of treatment in this delay could not be cleared because of the relatively low number of cases. Since, according to international data the post-pill return of fertility of nulliparas is slower than that of paras, the author highly recommends the use of multiphasic products for temporary contraception of nulliparas.

这项研究涉及停止使用各种口服避孕药后生育能力的恢复。根据对222个病例的数据的评价,得出以下结论:在停止使用口服避孕药一段较短或较长的时期后,可能会观察到生育能力恢复的延迟。在评估的病例中不超过7个月。与单相片剂相比,在使用多相片剂(Anteovin, Tri-Regol)后再生,即第一次排卵和随后的怀孕,发生在更短的时间内。由于病例数量相对较少,治疗时间在这种延误中所起的作用尚不清楚。由于国际上的资料显示,服用避孕药后无产妇恢复生育能力的速度要慢于无产妇,因此笔者强烈建议使用多相产品对无产妇进行临时避孕。
{"title":"How rapid is the return of fertility after the use of Tri-Regol oral contraceptive?","authors":"J Adám","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The study deals with the return of fertility following the discontinuance of the use of different oral contraceptives. On the basis of the evaluation of data of 222 cases the following were concluded: after the discontinuance of the use of oral contraceptives for a shorter-longer period delay may be observed in the return of fertility. This was not longer that 7 months in the evaluated cases. Compared to monophasic tablets, following the use of multiphasic tablets (Anteovin, Tri-Regol) regeneration, that is first ovulation and the following pregnancy, occur within a shorter period. The role of the duration of treatment in this delay could not be cleared because of the relatively low number of cases. Since, according to international data the post-pill return of fertility of nulliparas is slower than that of paras, the author highly recommends the use of multiphasic products for temporary contraception of nulliparas.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 1","pages":"16-9"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12753296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The theophylline dilemma. 茶碱困境。
Pub Date : 1992-01-01
I Vadász

The effectivity of recently introduced beta adrenergic agents in the USA prompted physicians to reevaluate the usefulness of theophylline having been used solely as a bronchodilator in the treatment of obstructive respiratory tract diseases. As part of a complex therapy applied in different diseases (acute asthmatic attacks, chronic asthma, acute exacerbation, and long-term treatment of obstructive bronchitis) theophylline is still a drug of value. The risk of toxicity can be reduced to a minimum. In the prevention of certain symptoms (e.g. nocturnal dyspnoea of asthmatics) (slow release) theophylline preparations proved to be the most advantageous. In aged patients technical difficulties limit the use of inhalation therapy, the oral applicability of theophylline is a further advantage of this product.

最近在美国引入的β肾上腺素能药物的有效性促使医生重新评估茶碱在治疗阻塞性呼吸道疾病中单独用作支气管扩张剂的有效性。作为应用于不同疾病(急性哮喘发作、慢性哮喘、急性加重和阻塞性支气管炎的长期治疗)的复杂疗法的一部分,茶碱仍然是一种有价值的药物。毒性的风险可以降低到最低限度。在预防某些症状(如哮喘患者夜间呼吸困难)(缓释)时,茶碱制剂被证明是最有利的。在老年患者技术困难限制吸入疗法的使用,茶碱的口服适用性是该产品的进一步优势。
{"title":"The theophylline dilemma.","authors":"I Vadász","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effectivity of recently introduced beta adrenergic agents in the USA prompted physicians to reevaluate the usefulness of theophylline having been used solely as a bronchodilator in the treatment of obstructive respiratory tract diseases. As part of a complex therapy applied in different diseases (acute asthmatic attacks, chronic asthma, acute exacerbation, and long-term treatment of obstructive bronchitis) theophylline is still a drug of value. The risk of toxicity can be reduced to a minimum. In the prevention of certain symptoms (e.g. nocturnal dyspnoea of asthmatics) (slow release) theophylline preparations proved to be the most advantageous. In aged patients technical difficulties limit the use of inhalation therapy, the oral applicability of theophylline is a further advantage of this product.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 1","pages":"3-7"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12753300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hormone therapy in breast cancer. 乳腺癌的激素治疗。
Pub Date : 1992-01-01
Z Kahán

Means and the currently accepted principles of hormone therapy of breast cancer have been summarized on the basis of data from references. Fields of application and adverse effects of anti-oestrogens, aromatase inhibitors, gestagens, gonadotrophin-releasing, and androgenic hormones have been analysed. Drugs with various mechanisms of action and available in Hungary have been discussed.

在文献资料的基础上,总结了乳腺癌激素治疗的手段和目前公认的原则。分析了抗雌激素、芳香化酶抑制剂、孕激素、促性腺激素和雄激素的应用领域和不良反应。讨论了具有各种作用机制和匈牙利可用的药物。
{"title":"Hormone therapy in breast cancer.","authors":"Z Kahán","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Means and the currently accepted principles of hormone therapy of breast cancer have been summarized on the basis of data from references. Fields of application and adverse effects of anti-oestrogens, aromatase inhibitors, gestagens, gonadotrophin-releasing, and androgenic hormones have been analysed. Drugs with various mechanisms of action and available in Hungary have been discussed.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 4","pages":"154-62"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12518216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Dormicum sleeping pills in everyday practice. 在日常练习中使用多米肯安眠药。
Pub Date : 1992-01-01
K Török

Dormicum is a rapidly absorbed up-to date hypnotic of 3-4 hours' duration of action physiologically influencing the phases of normal sleep. In the course of the examination of 26 patients, 21 found the hypnotic action of 7.5-mg or 15-mg Dormicum doses to be highly effective. The drug proved to be an effective hypnotic also in the group of patients above 60 years of age (14). It is of special importance in the everyday practice of a general practitioner that the intake of Dormicum in the evening did not influence the physical and mental activity of the patients the next day.

Dormicum是一种快速吸收的最新催眠药,持续3-4小时的作用在生理上影响正常睡眠的阶段。在对26例患者的检查过程中,有21例发现7.5 mg或15 mg剂量的多咪康催眠作用非常有效。该药被证明对60岁以上的患者也是有效的催眠药(14)。在全科医生的日常实践中,特别重要的是,晚上服用多米康不会影响患者第二天的身心活动。
{"title":"Use of Dormicum sleeping pills in everyday practice.","authors":"K Török","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Dormicum is a rapidly absorbed up-to date hypnotic of 3-4 hours' duration of action physiologically influencing the phases of normal sleep. In the course of the examination of 26 patients, 21 found the hypnotic action of 7.5-mg or 15-mg Dormicum doses to be highly effective. The drug proved to be an effective hypnotic also in the group of patients above 60 years of age (14). It is of special importance in the everyday practice of a general practitioner that the intake of Dormicum in the evening did not influence the physical and mental activity of the patients the next day.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"40 4","pages":"166-8"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12518218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapia Hungarica (English edition)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1